Qi S - Search Results

1

Efficacy and safety of first-line treatments with immune checkpoint inhibitors plus chemotherapy for non-squamous non-small cell lung cancer: a meta-analysis and indirect comparison.

Shi Y, Chen W, Li C, Zhang Y, Bo M, Qi S, Li G. Shi Y, et al. Among authors: qi s. Ann Palliat Med. 2021 Mar;10(3):2766-2775. doi: 10.21037/apm-20-1498. Epub 2021 Feb 1. Ann Palliat Med. 2021. PMID: 33549014 Free article.

2

Assessment on the Efficacy and Safety of Aidi Injection Combined with Vinorelbine and Cisplatin for Treatment of Advanced Nonsmall Cell Lung Cancer.

Zhao HY, Zhou HY, Wang YT, Chen W, Qi SY, Cao JL, Li GH. Zhao HY, et al. Chin Med J (Engl). 2016 Mar 20;129(6):723-30. doi: 10.4103/0366-6999.178016. Chin Med J (Engl). 2016. PMID: 26960377 Free PMC article.

3

[Standardization of names in prescriptions of traditional Chinese medicines].

Li CF, Zhang YJ, Fan DH, Zhang MJ, Bai X, Yang WH, Qi SY, Zhang ZJ, Xue CM, Mao LY, Cao JL. Li CF, et al. Zhongguo Zhong Yao Za Zhi. 2017 Jan;42(1):198-202. doi: 10.19540/j.cnki.cjcmm.20161222.038. Zhongguo Zhong Yao Za Zhi. 2017. PMID: 28945049 Chinese.

4

The modulatory properties of Si Jun Zi Tang enhancing anticancer of gefitinib by an integrating approach.

Li C, Niu M, Wang R, Zhou XW, Dong B, Qi S, Chen W, Zhang M, Shi Y, Li R, Li G. Li C, et al. Among authors: qi s. Biomed Pharmacother. 2019 Mar;111:1132-1140. doi: 10.1016/j.biopha.2018.12.026. Epub 2019 Jan 12. Biomed Pharmacother. 2019. PMID: 30841426 Free article.

5

Pharmacokinetic Study and Tissue Distribution of Lorlatinib in Mouse Serum and Tissue Samples by Liquid Chromatography-Mass Spectrometry.

Chen W, Shi Y, Qi S, Zhou H, Li C, Jin D, Li G. Chen W, et al. Among authors: qi s. J Anal Methods Chem. 2019 Mar 4;2019:7574369. doi: 10.1155/2019/7574369. eCollection 2019. J Anal Methods Chem. 2019. PMID: 30949374 Free PMC article.

6

Clinicopathological characteristics and prediction of cancer-specific survival in large cell lung cancer: a population-based study.

Shi Y, Chen W, Li C, Qi S, Zhou X, Zhang Y, Li Y, Li G. Shi Y, et al. Among authors: qi s. J Thorac Dis. 2020 May;12(5):2261-2269. doi: 10.21037/jtd.2020.04.24. J Thorac Dis. 2020. PMID: 32642131 Free PMC article.

7

Modulatory effects of Xihuang Pill on lung cancer treatment by an integrative approach.

Li C, Chen W, Zhang M, Zhang C, Cao B, Dong B, Qi S, Zhang Y, Fei X, Li X, Li R, Wang J, Li G. Li C, et al. Among authors: qi s. Biomed Pharmacother. 2020 Oct;130:110533. doi: 10.1016/j.biopha.2020.110533. Epub 2020 Jul 30. Biomed Pharmacother. 2020. PMID: 32739739 Free article.

8

An Integrative Metabolomic and Network Pharmacology Study Revealing the Regulating Properties of Xihuang Pill That Improves Anlotinib Effects in Lung Cancer.

Li C, Wang Z, Chen W, Cao B, Zhang M, Gu Q, Qi S, Fei X, Shi Y, Li X, Li R, Wang J, Li G. Li C, et al. Among authors: qi s. Front Oncol. 2021 Aug 9;11:697247. doi: 10.3389/fonc.2021.697247. eCollection 2021. Front Oncol. 2021. PMID: 34434895 Free PMC article.

9

An integrative lipidomics and transcriptomics study revealing Bavachin and Icariin synergistically induce idiosyncratic liver injury.

Li Y, Cao B, Lin M, Xu J, Qi S, Wang J, Xiao X, Li G, Li C. Li Y, et al. Among authors: qi s. Immunopharmacol Immunotoxicol. 2024 Dec;46(6):924-934. doi: 10.1080/08923973.2024.2424293. Epub 2024 Nov 6. Immunopharmacol Immunotoxicol. 2024. PMID: 39505304

10

Analysis of a lung cancer case with transient pseudo hypoglycemia after PEG-rhG-CSF treatment.

Qi S, Liu L. Qi S, et al. Heliyon. 2024 Jun 18;10(12):e33074. doi: 10.1016/j.heliyon.2024.e33074. eCollection 2024 Jun 30. Heliyon. 2024. PMID: 39005902 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,058 results

Search Page

Filters